<?xml version="1.0"?>

<document>
	<title>Pseudomonas aeruginosa infection in cystic fibrosis.  Occurrence of
   precipitating antibodies against pseudomonas aeruginosa in relation
   to the concentration of sixteen serum proteins and the clinical and
   radiographical status of the lungs.</title>

	<author>Hoiby-N.</author>
	<author>Jacobsen-L.</author>
	<author>Jorgensen-B-A.</author>
	<author>Lykkegaard-E.</author>
	<author>Weeke-B.</author>

	<source>Acta-Paediatr-Scand. 1974 Nov. 63(6). P 843-8.</source>

	<abstract>The significance of Pseudomonas aeruginosa infection in the
   respiratory tract of 9 cystic fibrosis patients have been studied
   by means of immunoelectrophoretical analysis of patients&apos; sera for
   the number of precipitins against Pseudomonas aeruginosa and the
   concentrations of 16 serum proteins.  In addition, the clinical and
   radiographical status of the lungs have been evaluated using 2
   scoring systems.  Precipitins against Pseudomonas aeruginosa were
   demonstrated in all sera, the maximum number in one serum was 22.
   The concentrations of 12 of the serum proteins were significantly
   changed compared with matched control persons.  Notably IgG and IgA
   were elevated and the &quot;acute phase proteins&quot; were changed, the
   latter suggesting active tissue damage.  The concentrations of 3 of
   the acute phase proteins, notably haptoglobin, were correlated to
   the number of precipitins suggesting that the respiratory tract
   infection in patients with many precipitins is accompanied by more
   tissue damage than the infection in patients with few precipitins.
   The results indicate no protective value of the many precipitins on
   the tissue of the respiratory tract.</abstract>

	<majorsubject>CYSTIC-FIBROSIS: co</majorsubject>
	<majorsubject>PSEUDOMONAS-AERUGINOSA: im</majorsubject>
	<majorsubject>PSEUDOMONAS-INFECTIONS: co</majorsubject>
	<majorsubject>RESPIRATORY-TRACT-INFECTIONS: co</majorsubject>

	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>BLOOD-PROTEINS: me</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>CHILD-PRESCHOOL</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: im, bl</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>IMMUNOELECTROPHORESIS</minorsubject>
	<minorsubject>IMMUNOGLOBULINS: me</minorsubject>
	<minorsubject>LUNG: ra</minorsubject>
	<minorsubject>MALE</minorsubject>
	<minorsubject>PRECIPITIN-TESTS</minorsubject>
	<minorsubject>PRECIPITINS</minorsubject>
	<minorsubject>PSEUDOMONAS-INFECTIONS: im, bl, ra</minorsubject>
	<minorsubject>RESPIRATORY-TRACT-INFECTIONS: bl, im, ra</minorsubject>
	<minorsubject>SERUM-ALBUMIN: me</minorsubject>

	<reference>001   BELFRAGE S            ACTA MED SCAND SUPPL           173     5 963</reference>
	<reference>002   COOMBS RRA            IN: GELL PGH                         317 964</reference>
	<reference>003   DIEM K                DOCUMENTA GEIGY SCIENTIFIC TA            962</reference>
	<reference>004   DOGGETT RG            J PEDIATR                       68   215 966</reference>
	<reference>005   DOGGETT RG            IN: LAWSON D PROC 5TH INT CF         175 969</reference>
	<reference>006   DOGGETT RG            INFECT IMMUN                     6   628 972</reference>
	<reference>007   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   81   298 973</reference>
	<reference>009   KOCH C                ACTA PATH MICROBIOL SCAND (B)   81   787 973</reference>
	<reference>010   LUNDH B               ACTA UNIV LUND II               24     1 965</reference>
	<reference>011$  LUNDH B               ACTA UNIV LUND II               27     1 965</reference>
	<reference>012   MINCHIN-CLARKE HG     THORAX                          25   423 970</reference>
	<reference>013   MULLER HE             DTSCH MED WSCHR                 93   120 968</reference>
	<reference>014   NORMAN AP             PROC EWGCF 2ND ANNU MTG                  971</reference>
	<reference>015   NYMAN M               SCAND J CLIN LAB INVEST SUPPL   39     5 959</reference>
	<reference>016   WEEKE B               ACTA MED SCAND                 192   149 972</reference>
	<reference>017   WEEKE B               THESIS                                 1 973</reference>
	<reference>018   WEEKE B               SCAND J IMMUNOL SUPPL 1          2    37 973</reference>
	<reference>019   WEEKE B               SCAND J IMMUNOL SUPPL 2          1    48 973.</reference>

	<citation>1   HOIBY N               SCAND J RESPIR DIS              56    38 975</citation>
	<citation>2   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   83   459 975</citation>
	<citation>3   AXELSON NH            SCAND J IMMUNOL                  5   177 976</citation>
	<citation>4   GARGANI GF            ANN SCLAVO                      18   179 976</citation>
	<citation>5   WEEKE B               DAN MED BULL                    23   155 976</citation>
	<citation>6   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977</citation>
	<citation>7   HOIBY N               SCAND J RESPIR DIS              58    65 977</citation>
	<citation>8   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   85    57 977</citation>
	<citation>9   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   86    37 978</citation>
	<citation>10   KLINGER JD            J INFECT DIS                   138    49 978</citation>
	<citation>11   MCCARTHY MM           CLIN PEDIATR                    19   746 980</citation>
	<citation>12   MOSS RB               AM REV RESPIR DIS              121    23 980</citation>
	<citation>13   MOSS RB               J PEDIATR                       99   215 981</citation>
	<citation>14   BECK B                ACTA PAEDIATR SCAND SUPPL 301 1982   125 982</citation>
	<citation>15   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    63 982</citation>
	<citation>16   SCHIOTZ PO            ACTA PAEDIATR SCAND SUPPL 301 1982    55 982</citation>
	<citation>17   MARHAUG G             ACTA PAEDIATR SCAND             72   861 983</citation>
	<citation>18   MCGLENNEN RC          ARCH PATHOL LAB MED            110   879 986</citation>
	<citation>19   EMMETT M              PROC SOC EXP BIOL MED          184    74 987</citation>

</document>
